Avanos Medical (AVNS) Profit After Tax (2013 - 2026)

Avanos Medical has reported Profit After Tax for 14 years, with the latest figure at $5.1 million in Q1 2026.

• Quarterly Profit After Tax fell 22.73% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.4 million (up 80.93% YoY) and the FY2025 annual result came in at -$72.9 million, up 81.41% from the prior year.
• Profit After Tax advanced to $5.1 million in Q1 2026 per AVNS's latest filing, from -$1.3 million in the prior quarter.
• Over five years, Profit After Tax peaked at $16.9 million in Q4 2022 and troughed at -$402.8 million in Q4 2024.
• A 5-year average of -$24.6 million and a median of $1.8 million in 2024 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 833.33% in 2025, down 4366.67% in 2025.
• Over 5 years, Profit After Tax stood at $16.9 million in 2022, then sank by 34.91% to $11.0 million in 2023, then tumbled by 3761.82% to -$402.8 million in 2024, then jumped by 99.68% to -$1.3 million in 2025, then jumped by 492.31% to $5.1 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered $5.1 million, -$1.3 million, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.